Element Capital Management LLC Chemo Centryx, Inc. Transaction History

Element Capital Management LLC

$2.17 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $98,938 - $176,804	-11,906 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$10.01 - $13.89 $119,179 - $165,374	11,906 New	11,906 $165,000
Q4 2018 Feb 13, 2019	SELL	$9.15 - $12.26 $314,997 - $422,062	-34,426 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$10.49 - $13.72 $54,548 - $71,344	-5,200 Reduced 13.12%	34,426 $435,000
Q2 2018 Aug 14, 2018	BUY	$10.62 - $13.98 $267,337 - $351,918	25,173 Added 174.17%	39,626 $522,000
Q1 2018 May 15, 2018	BUY	$5.9 - $14.99 $85,272 - $216,650	14,453 New	14,453 $197,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Element Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Element Capital Management LLC with notifications on news.